These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22401339)

  • 1. Continuous glucose monitoring-guided insulin dosing in pump-treated patients with type 1 diabetes: a clinical guide.
    King AB
    J Diabetes Sci Technol; 2012 Jan; 6(1):191-203. PubMed ID: 22401339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View.
    Freckmann G; Schlüter S; Heinemann L;
    J Diabetes Sci Technol; 2017 Jul; 11(4):653-656. PubMed ID: 28745088
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a novel continuous glucose monitoring guided system for adjustment of insulin dosing - PumpTune: a randomized controlled trial.
    Anderson D; Phelan H; Jones K; Smart C; Oldmeadow C; King B; Crock P
    Pediatr Diabetes; 2016 Nov; 17(7):478-482. PubMed ID: 26701831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
    Pettus J; Edelman SV
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.
    King AB
    Endocr Pract; 2009 Apr; 15(3):229-33. PubMed ID: 19364691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
    Grunberger G; Handelsman Y; Bloomgarden ZT; Fonseca VA; Garber AJ; Haas RA; Roberts VL; Umpierrez GE
    Endocr Pract; 2018 Mar; 24(3):302-308. PubMed ID: 29547046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
    Fabris C; Ozaslan B; Breton MD
    Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678
    [No Abstract]   [Full Text] [Related]  

  • 14. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel adaptive basal therapy based on the value and rate of change of blood glucose.
    Wang Y; Percival MW; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2009 Sep; 3(5):1099-108. PubMed ID: 20144423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin pump regulated by a glucose sensor; one step closer to closing the loop for type 1 diabetes patients].
    de Valk HW
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials.
    Szypowska A; Ramotowska A; Dzygalo K; Golicki D
    Eur J Endocrinol; 2012 Apr; 166(4):567-74. PubMed ID: 22096111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.
    Hughes CS; Patek SD; Breton MD; Kovatchev BP
    J Diabetes Sci Technol; 2010 Sep; 4(5):1146-55. PubMed ID: 20920434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
    King AB; Clark D; Wolfe GS
    Diabetes Technol Ther; 2012 Oct; 14(10):900-3. PubMed ID: 22845649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.